全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

晚期肺腺癌合并肺栓塞临床特征分析及D-二聚体对其预测价值
Analysis of Clinical Characteristics of Advanced Lung Adenocarcinoma with Pulmonary Embolism and Predictive Value of D-Dimer

DOI: 10.12677/acm.2024.1441074, PP. 663-671

Keywords: 肺腺癌,肺栓塞,D-二聚体,危险因素
Lung Adenocarcinoma
, Pulmonary Embolism, D-Dimer, Risk Factors

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的:探讨晚期肺腺癌合并肺栓塞患者的临床特征,分析D-二聚体对其预测价值。方法:选取2015.01~2020.01在我院诊断为晚期肺腺癌合并肺栓塞的59例患者为研究对象,收集同期59例肺晚期腺癌不合并肺栓塞患者作为对照组,记录入组患者临床资料,使用SPSS25.0软件进行分析。结果:晚期肺腺癌合并肺栓塞组的D-二聚体的水平明显高于对照组(P < 0.001),Spearman相关分析提示D-二聚体水平与晚期肺腺癌合并肺栓塞的具有高度相关性(r= 0.602, P < 0.001);受试者工作特征曲线(ROC)显示:D-二聚体预测肺癌合并肺栓塞的AUC值0.848 (95% CI: 0.779~0.919),最佳临界值1365 ng/L,此时灵敏度为81.4%,特异度为79.7%。结论:D-二聚体是晚期肺腺癌合并肺栓塞的独立危险因素,D-二聚体的临界值大于1365 ng/L时,对晚期肺腺癌合并肺栓塞有重要的预测价值。
Objective: To investigate the clinical features of patients with advanced lung adenocarcinoma complicated with pulmonary embolism, and to analyze the predictive value of D-dimer. Methods: Fifty-nine patients diagnosed with advanced pulmonary adenocarcinoma complicated with pulmonary embolism in our hospital were selected as study group from 2015.01~2020.01, and 59 patients with advanced pulmonary adenocarcinoma without pulmonary embolism were collected as the control group. The clinical data information of the patient was recorded, the results were analyzed by SPSS25.0. Result: The levels of D-dimer were significantly increased in the study group compared with control group (P < 0.001). Spearman correlation showed that the levels of D-dimer was highly correlated with the lung adenocarcinoma combined with PE (r = 0.602, P < 0.001); The area under the Receiver Operating Characteristic Curve (ROC) showed that value of D-dimer predicted advanced lung adenocarcinoma combined with PE was 0.848 (95% CI: 0.779~0.919), and cut-off value was 1365 ng/L. At this time, the sensitivity and specificity were 81.4% and 79.7% respectively. Conclusion: D-dimer is an independent risk factor for advanced lung adenocarcinoma with pulmonary embolism. When the cut-off value of D-dimer is greater than 1365 ng/L, it has important predictive value for the disease.

References

[1]  Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424.
https://doi.org/10.3322/caac.21492
[2]  Barta, J.A., Powell, C.A. and Wisnivesky, J.P. (2019) Global Epidemiology of Lung Cancer. Annals of Global Health, 85, Article 8.
https://doi.org/10.5334/aogh.2419
[3]  Di Nisio, M. and Carrier, M. (2017) Incidental Venous Thromboembolism: Is Anticoagulation Indicated? Hematology: American Society of Hematology Education Program, 2017, 121-127.
https://doi.org/10.1182/asheducation-2017.1.121
[4]  孙薇, 王海燕, 文仲光, 等. 肺癌并发肺栓塞患者的临床特征[J]. 中华结核和呼吸杂志, 2016, 39(3): 198-202.
[5]  Gi, T., Kuwahara, A., Yamashita, A., et al. (2023) Histopathological Features of Cancer-Associated Venous Thromboembolism: Presence of Intrathrombus Cancer Cells and Prothrombotic Factors. Arteriosclerosis, Thrombosis, and Vascular Biology, 43, 146-159.
https://doi.org/10.1161/ATVBAHA.122.318463
[6]  Grover, S.P., Hisada, Y.M., Kasthuri, R.S., et al. (2021) Cancer Therapy-Associated Thrombosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 41, 1291-1305.
https://doi.org/10.1161/ATVBAHA.120.314378
[7]  Feng, S.H. and Yang, S.T. (2019) The New 8th TNM Staging System of Lung Cancer and Its Potential Imaging Interpretation Pitfalls and Limitations with CT Image Demonstrations. Diagnostic and Interventional Radiology, 25, 270-279.
https://doi.org/10.5152/dir.2019.18458
[8]  Kay, F.U., Kandathil, A., Batra, K., et al. (2017) Revisions to the Tumor, Node, Metastasis Staging of Lung Cancer (8th Edition): Rationale, Radiologic Findings and Clinical Implications. World Journal of Radiology, 9, 269-279.
https://doi.org/10.4329/wjr.v9.i6.269
[9]  徐英江, 金毕, 杨超, 等. 459例肺栓塞临床特点分析[J]. 中华普通外科杂志, 2015, 30(12): 979-982.
[10]  Pintarelli, G., Noci, S., Maspero, D., et al. (2019) Cigarette Smoke Alters the Transcriptome of Non-Involved Lung Tissue in Lung Adenocarcinoma Patients. Scientific Reports, 9, Article 13039.
https://doi.org/10.1038/s41598-019-49648-2
[11]  Whitson, B.A., Groth, S.S., Andrade, R.S., et al. (2012) T1/T2 Non-Small-Cell Lung Cancer Treated by Lobectomy: Does Tumor Anatomic Location Matter? Journal of Surgical Research, 177, 185-190.
https://doi.org/10.1016/j.jss.2012.05.022
[12]  蒲纯, 许小毛, 乔力松, 等. 恶性肿瘤并发静脉血栓栓塞症的临床分析[J]. 中华老年多器官疾病杂志, 2016, 15(11): 810-814.
[13]  Duffy, M.J. and O’Byrne, K. (2018) Tissue and Blood Biomarkers in Lung Cancer: A Review. Advances in Clinical Chemistry, 86, 1-21.
https://doi.org/10.1016/bs.acc.2018.05.001
[14]  Jiao, X.D., Qin, B.D., You, P., et al. (2018) The Prognostic Value of TP53 and Its Correlation with EGFR Mutation in Advanced Non-Small Cell Lung Cancer, an Analysis Based on cBioPortal Data Base. Lung Cancer, 123, 70-75.
https://doi.org/10.1016/j.lungcan.2018.07.003
[15]  Lysov, Z., Swystun, L.L., Kuruvilla, S., et al. (2015) Lung Cancer Chemotherapy Agents Increase Procoagulant Activity via Protein Disulfide Isomerase-Dependent Tissue Factor Decryption. Blood Coagulation & Fibrinolysis, 26, 36-45.
https://doi.org/10.1097/MBC.0000000000000145
[16]  Garon, E.B., Hellmann, M.D., Rizvi, N.A., et al. (2019) Five-Year Overall Survival for Patients with Advanced Non-Small-Cell Lung Cancer Treated with Pembrolizumab: Results from the Phase I KEYNOTE-001 Study. Journal of Clinical Oncology, 37, 2518-2527.
https://doi.org/10.1200/JCO.19.00934
[17]  Ma, L. and Wen, Z. (2017) Risk Factors and Prognosis of Pulmonary Embolism in Patients with Lung Cancer. Medicine, 96, e6638.
https://doi.org/10.1097/MD.0000000000006638
[18]  邱冬. 肺癌并发肺栓塞的危险因素[J]. 中国血液流变学杂志, 2018, 28(4): 409-411.
[19]  李慧芳. 肺癌合并肺栓塞临床特点回顾性分析[J]. 世界最新医学信息文摘(连续型电子期刊), 2018, 18(72): 1-3, 13.
[20]  田学涛, 黄吉利. 肺癌患者肺栓塞的危险因素研究[J]. 实用心脑肺血管病杂志, 2017, 25(2): 50-52.
[21]  Zhang, Y., Yang, Y., Chen, W., et al. (2014) Prevalence and Associations of VTE in Patients with Newly Diagnosed Lung Cancer. Chest, 146, 650-658.
https://doi.org/10.1378/chest.13-2379
[22]  Cui, Y.Q., Tan, X.M., Liu, B., et al. (2020) Analysis on Risk Factors of Lung Cancer Complicated with Pulmonary Embolism. The Clinical Respiratory Journal, 15, 65-73.
https://doi.org/10.1111/crj.13270
[23]  Xiong, W., Zhao, Y., Xu, M., et al. (2017) The Relationship between Tumor Markers and Pulmonary Embolism in Lung Cancer. Oncotarget, 8, 41412-41421.
https://doi.org/10.18632/oncotarget.17916

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133